Otho S.A. Sprague Memorial Institute awards Rush nearly $125,000 for new patient-safe...(consistently used our grants to achieve ...),Health
Navigation Links
Otho S.A. Sprague Memorial Institute awards Rush nearly $125,000 for new patient-safety project
Date:2/22/2008
consistently used our grants to achieve our shared vision. We are confident these grants will continue this pattern of significant outcomes that promote health, improve care, and reduce costs through innovation said James N. Alexander, The Institutes Executive Director.
'/>"/>
| Contact: Mary Ann Schultz mary_ann_schultz@rush.edu 312-942-7816 Rush University Medical Center Source:Eurekalert |
Related medicine news :
1. Otho S.A. Sprague Memorial Institute awards Rush $230,000 for childhood obesity prevention
2. MemorialCare Medical Centers CEO Barry Arbuckle Elected Chair of California Hospital Association
3. Sharp Memorial Hospital Achieves Highest Honor for Nursing Excellence
4. Northwestern Memorial HealthCare and Northwestern Memorial Foundation Elect New Members to Board of Directors
5. Northwestern Memorials Heart Center Pioneers Minimally Invasive Surgery That Corrects Irregular Heart Beat
6. Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery
7. ...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National Win an MRI Contest
8. GREENGUARD 2008 Memorial Fellowship Winners Will Examine Design
9. A Fort Worth Couple Sues Huguley Memorial Medical Center
10. Pennsylvania Invests $13.4 Million to Kick Off Butler Memorial Hospital Expansion
11. Dr. Lewis Drusin receives American College of Physicians James D. Bruce Memorial Award
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Adding Chemo to Tamoxifen Helps Some Breast Cancer Patients 2Health News:Adding Chemo to Tamoxifen Helps Some Breast Cancer Patients 3Health News:FEHBP Open Enrollment Period to be Discussed on Special Rebroadcast of 'Inside Government' 2Health News:Black Community Unites Against HIV/AIDS Epidemic 2Health News:Bone Drugs May Beat Back Breast Cancer 2Health News:Macomb County Announces New Location for Four Upcoming H1N1 Clinics 2
[0] Adding Chemo to Tamoxifen Helps Some Breast Cancer Patients [0] FEHBP Open Enrollment Period to be Discussed on Special Rebroadcast of 'Inside Government'[0] Black Community Unites Against HIV/AIDS Epidemic[0] Bone Drugs May Beat Back Breast Cancer[0] Macomb County Announces New Location for Four Upcoming H1N1 Clinics
Other Medicine News:Health News:Los Angeles Jury Convicts Defendant of Fraud Involving More Than $1.1 Million in False Billing to Medicare 2Health News:Los Angeles Jury Convicts Defendant of Fraud Involving More Than $1.1 Million in False Billing to Medicare 3Health News:Heart Attack Care Often Delayed for the Poor 2Health News:Heart Attack Care Often Delayed for the Poor 3Health News:Pro-Life Chair to Congress: 'We Can't Reduce Abortions By Promoting Abortion' 2Health News:Improved healthfinder.gov Makes Health Information Quicker and Easier to Use 2Health News:Improved healthfinder.gov Makes Health Information Quicker and Easier to Use 3
Los Angeles Jury Convicts Defendant of Fraud Involving More Than $1.1 Million in False Billing to MedicareHeart Attack Care Often Delayed for the PoorPro-Life Chair to Congress: 'We Can't Reduce Abortions By Promoting Abortion'Improved healthfinder.gov Makes Health Information Quicker and Easier to UseFamily History Key Player in Brain Cancer RiskWest Increases Quarterly Dividend
Breaking Medicine Technology:New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 1Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 2Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 3Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 4Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records 28EHRs 29 53831 5Former Microsoft Healthcare Executive Joins iMedExchange 53828 1Former Microsoft Healthcare Executive Joins iMedExchange 53828 2Gold Standard Elsevier Launches MedCounselor Consumer Drug Information Modules 53825 1Gold Standard Elsevier Launches MedCounselor Consumer Drug Information Modules 53825 2Gold Standard Elsevier Launches MedCounselor Consumer Drug Information Modules 53825 3
[0] New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals[0] Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection[0] AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens
Other Medicine Technology:Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 2Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 3Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 4CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 2CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 3CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 4CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 5CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone 6
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |